Audrey Claire Benson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Audrey Claire Benson has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Davide Rasella
Institute of Collective Health (ISC) at the Federal University of Bahia (UFBA), Salvador, Brazil
2 shared publications - Elisa Landin-Basterra
ISGlobal, Barcelona, Spain
2 shared publications - Gonzalo Barreix2 shared publications
- Lucas Sales
Programa de Pós-Graduação em Matemática Aplicada e Estatística, Universidade Federal do Rio Grande do Norte, Natal, Brazil
2 shared publications - Peter Kirwan
MRC Biostatistics Unit, University of Cambridge
2 shared publications A Terzidis
Global Health and Disaster Medicine, National and Kapodistrian University of Athens, School of Health Sciences, Athens, Attica, Greece
1 shared publication
Latest Publications
- 22 October 2026
- Published by Wiley in HIV Medicine
Sex‐ and migration‐related differences in viral suppression and life expectancy among people with HIV : The PISCIS cohort, 1998–2023
Background: Despite advances in antiretroviral therapy (ART), inequalities in HIV outcomes persist by sex and migration status. Few studies have examined how these factors jointly relate to treatment outcomes across successive ART eras. Aim: To examine differences in time to first viral suppression and life expectancy according to sex and migration status, and how these differences changed across successive ART eras. Methods: We conducted a population‐based retrospective cohort study using the PISCIS cohort in Catalonia and the Balearic Islands, Spain. Participants aged ≥16 years diagnosed with HIV between 1998 and 2023, with a recorded ART initiation date and at least one viral load measurement within 12 months after ART initiation, were included. Time to first viral suppression (p < 0.001): Migrant women had a lower adjusted hazard of viral suppression than migrant MSM (aHR 0.77, 95% CI 0.67–0.89), while a particularly low hazard was observed among migrant heterosexual men (aHR 0.60, 95% CI 0.51–0.69). Life expectancy at age 20 increased by approximately 12 years across all groups over the study period, with differences between groups narrowing over time. Conclusion: Viral suppression and life expectancy improved substantially across all sex‐migration groups over 26 years. However, differences in time to viral suppression persisted in the most recent ART era, including slower suppression among migrant women compared with migrant men. Further disaggregation of sexually acquired HIV revealed additional heterogeneity, particularly between migrant MSM and heterosexual men. These findings highlight the importance of considering the intersection of sex, migration status and HIV acquisition group to better identify population‐specific inequalities in HIV care.
- 22 October 2026
- Published by Wiley in HIV Medicine
Sex‐ and migration‐related differences in viral suppression and life expectancy among people with HIV : The PISCIS cohort, 1998–2023
Background: Despite advances in antiretroviral therapy (ART), inequalities in HIV outcomes persist by sex and migration status. Few studies have examined how these factors jointly relate to treatment outcomes across successive ART eras. Aim: To examine differences in time to first viral suppression and life expectancy according to sex and migration status, and how these differences changed across successive ART eras. Methods: We conducted a population‐based retrospective cohort study using the PISCIS cohort in Catalonia and the Balearic Islands, Spain. Participants aged ≥16 years diagnosed with HIV between 1998 and 2023, with a recorded ART initiation date and at least one viral load measurement within 12 months after ART initiation, were included. Time to first viral suppression (p < 0.001): Migrant women had a lower adjusted hazard of viral suppression than migrant MSM (aHR 0.77, 95% CI 0.67–0.89), while a particularly low hazard was observed among migrant heterosexual men (aHR 0.60, 95% CI 0.51–0.69). Life expectancy at age 20 increased by approximately 12 years across all groups over the study period, with differences between groups narrowing over time. Conclusion: Viral suppression and life expectancy improved substantially across all sex‐migration groups over 26 years. However, differences in time to viral suppression persisted in the most recent ART era, including slower suppression among migrant women compared with migrant men. Further disaggregation of sexually acquired HIV revealed additional heterogeneity, particularly between migrant MSM and heterosexual men. These findings highlight the importance of considering the intersection of sex, migration status and HIV acquisition group to better identify population‐specific inequalities in HIV care.
- Open Access
- 18 September 2026
- Published by Elsevier in SSRN Electronic Journal
Mitigating the Effects of Humanitarian and Development Assistance Defunding on Child Mortality and Undernutrition in 62 Low-and Middle-Income Countries: An Integrated Retrospective and Forecasting Study of 11.2 Million Child-Years over three decades (2002-2035)
Background. Concerns have been raised about the potential negative consequences of recent large scale reductions in Official Development Assistance (ODA) funding to lower-and-middle-income-countries (LMICs). This study aimed to comprehensively evaluate the impact of ODA funding on under-five (U5) mortality and undernutrition over the past two decades, and to assess the potential health effects of alternative mitigation strategies in response to current ODA defunding trends, including donors meeting the target of 0.7% of gross national income (GNI) for ODA and the short-term reallocation of debt-related payments. Methods. We conducted an integrated retrospective evaluation and forecasting analysis using longitudinal individual-level data from 62 LMICs during 2002–2035, comprising 11.2 million child-years. First, we estimated the associations between ODA per capita and U5 mortality, wasting, stunting, and other healthcare outcomes using two-way fixed-effects multivariable Poisson regression models with robust standard errors, adjusted for all relevant demographic, socioeconomic, and health-system covariates. We then assessed heterogeneity according to sex, area of residence, and wealth level, and conducted sensitivity and triangulation analyses to evaluate the robustness and causal interpretation of the findings. Finally, we integrated the retrospective estimates into calibrated dynamic microsimulation models to project U5 mortality and undernutrition outcomes through 2035 under different ODA funding scenarios. Findings. Higher ODA funding levels were associated with 26% lower U5 mortality (incidence rate ratio (IRR) 0.74; 95% confidence interval (CI) 0.70-0.78), 47% lower prevalence of severe U5 stunting (prevalence ratio (PR) 0.53; 95% CI 0.50-0.57), and 65% lower prevalence of severe U5 wasting (PR 0.35; 95% CI 0.29-0.41). They were also associated with a 55% higher prevalence of births delivered in a medical facility (PR 1·55; 95% CI 1·53–1·58), a 49% higher prevalence of antenatal care (ANC) initiation in the first trimester (PR 1·49; 95% CI 1·44–1·54), and a 34% higher prevalence of eight or more ANC visits (PR 1·34; 95% CI 1·21–1·49). Associations were stronger in rural areas and lower-income groups. Over 2027-2035 in the selected 62 LMICs, an estimated 2.11 million (95% uncertainty interval (UI): 0.61–3.55 million) U5 deaths were averted in the debt-interest reallocation scenario, 3.84 million (1.83–5.72 million) in the debt service scenario, and 4.55 million (2.46–6.57 million) in the donor GNI 0.7% scenario. Corresponding estimates of averted stunting and wasting case-years were 46.3 million (36.0-57.0 million) and 27.4 million (19.0-36.4 million) for debt-interest reallocation, respectively; 92.9 million (78.0-109.0 million) and 53.2 million (39.3-67.6 million) for debt-service reallocation; and 106.1 million (93.0-119.3 million) and 54.0 million (43.8-65.1 million) for the donor GNI 0.7% scenario. Interpretation. Higher ODA funding has played a decisive role in reducing avoidable child mortality and undernutrition across LMICs over the past two decades. The abrupt withdrawal of this support threatens to undermine this progress and impose a substantial health burden on children worldwide. Conversely, mitigation policies involving increased donor funding and the short-term reallocation of debt-related payments could avert millions of child deaths and cases of undernutrition over the next decade.
- 18 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMitigating the Effects of Humanitarian and Development Assistance Defunding on Child Mortality and Undernutrition in 62 Low-and Middle-Income Countries: An Integrated Retrospective and Forecasting Study of 11.2 Million Child-Years over three decades (2002-2035)
Background. Concerns have been raised about the potential negative consequences of recent large scale reductions in Official Development Assistance (ODA) funding to lower-and-middle-income-countries (LMICs). This study aimed to comprehensively evaluate the impact of ODA funding on under-five (U5) mortality and undernutrition over the past two decades, and to assess the potential health effects of alternative mitigation strategies in response to current ODA defunding trends, including donors meeting the target of 0.7% of gross national income (GNI) for ODA and the short-term reallocation of debt-related payments. Methods. We conducted an integrated retrospective evaluation and forecasting analysis using longitudinal individual-level data from 62 LMICs during 2002–2035, comprising 11.2 million child-years. First, we estimated the associations between ODA per capita and U5 mortality, wasting, stunting, and other healthcare outcomes using two-way fixed-effects multivariable Poisson regression models with robust standard errors, adjusted for all relevant demographic, socioeconomic, and health-system covariates. We then assessed heterogeneity according to sex, area of residence, and wealth level, and conducted sensitivity and triangulation analyses to evaluate the robustness and causal interpretation of the findings. Finally, we integrated the retrospective estimates into calibrated dynamic microsimulation models to project U5 mortality and undernutrition outcomes through 2035 under different ODA funding scenarios. Findings. Higher ODA funding levels were associated with 26% lower U5 mortality (incidence rate ratio (IRR) 0.74; 95% confidence interval (CI) 0.70-0.78), 47% lower prevalence of severe U5 stunting (prevalence ratio (PR) 0.53; 95% CI 0.50-0.57), and 65% lower prevalence of severe U5 wasting (PR 0.35; 95% CI 0.29-0.41). They were also associated with a 55% higher prevalence of births delivered in a medical facility (PR 1·55; 95% CI 1·53–1·58), a 49% higher prevalence of antenatal care (ANC) initiation in the first trimester (PR 1·49; 95% CI 1·44–1·54), and a 34% higher prevalence of eight or more ANC visits (PR 1·34; 95% CI 1·21–1·49). Associations were stronger in rural areas and lower-income groups. Over 2027-2035 in the selected 62 LMICs, an estimated 2.11 million (95% uncertainty interval (UI): 0.61–3.55 million) U5 deaths were averted in the debt-interest reallocation scenario, 3.84 million (1.83–5.72 million) in the debt service scenario, and 4.55 million (2.46–6.57 million) in the donor GNI 0.7% scenario. Corresponding estimates of averted stunting and wasting case-years were 46.3 million (36.0-57.0 million) and 27.4 million (19.0-36.4 million) for debt-interest reallocation, respectively; 92.9 million (78.0-109.0 million) and 53.2 million (39.3-67.6 million) for debt-service reallocation; and 106.1 million (93.0-119.3 million) and 54.0 million (43.8-65.1 million) for the donor GNI 0.7% scenario. Interpretation. Higher ODA funding has played a decisive role in reducing avoidable child mortality and undernutrition across LMICs over the past two decades. The abrupt withdrawal of this support threatens to undermine this progress and impose a substantial health burden on children worldwide. Conversely, mitigation policies involving increased donor funding and the short-term reallocation of debt-related payments could avert millions of child deaths and cases of undernutrition over the next decade.
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
The Impact of Achieving Universal Social Protection on Under-5 Mortality in 37 Low- and Middle-Income Countries: An Integrated Retrospective and Forecasting Study of 7.7 Million Child-Years, 2000–2035
Background: Universal social protection (USP) is increasingly recognised as a key strategy for reducing poverty and health inequalities. Our study aims to evaluate the impact of expanding comprehensive social protection (SP) on under-5 mortality across low- and middle-income countries (LMICs) over the past two decades, and to forecast the effects of achieving USP compared with scenarios of SP deterioration. Methods: This retrospective impact evaluation integrated with forecasting analyses, used individual-level longitudinal data comprising 3.1 million child-years between 2000 and 2019 from 37 LMICs. We fitted two-way fixed-effects multivariable Poisson regression models with robust standard errors to estimate the effects of SP expansion on under-5 mortality, while assessing effect heterogeneity and performing extensive sensitivity and triangulation analyses. We subsequently integrated the retrospective data and effect estimates into validated dynamic microsimulation models based on 4.6 million child-years to forecast outcomes through 2035. Findings: A 10-percentage-point increase in SP coverage was associated with a 2·2% reduction in under-5 mortality (IRR:0·80;95%CI:0·70–0·92) between 2000 and 2019. The associations were stronger among children aged 1–4 years (IRR:0·54;95%CI:0·38–0·78), in rural populations (IRR:0·78;95%CI:0·67–0·90), and in low-income countries (IRR:0·67;95%CI:0·58–0·78). We estimated that observed SP expansion over the two-decade study period could have averted 3·34 million child deaths (95%CI:1·22–5·46). Forecasting analyses projected that achieving USP by 2035 could avert 2.46 million child deaths (95%UI:0·92–3·83) across the LMICs under study. Conversely, declines in SP coverage could lead to 1.00 million additional avoidable child deaths (95%UI:0·35–1·59). Interpretation: Achieving USP, as envisaged by target 1.3 of the 2030 Agenda for Sustainable Development, could substantially reduce child mortality in LMICs. Conversely, reduction in existing SP coverage due to declining development assistance and increasing fiscal austerity could result in substantial numbers of avoidable child deaths.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe Impact of Achieving Universal Social Protection on Under-5 Mortality in 37 Low- and Middle-Income Countries: An Integrated Retrospective and Forecasting Study of 7.7 Million Child-Years, 2000–2035
Background: Universal social protection (USP) is increasingly recognised as a key strategy for reducing poverty and health inequalities. Our study aims to evaluate the impact of expanding comprehensive social protection (SP) on under-5 mortality across low- and middle-income countries (LMICs) over the past two decades, and to forecast the effects of achieving USP compared with scenarios of SP deterioration. Methods: This retrospective impact evaluation integrated with forecasting analyses, used individual-level longitudinal data comprising 3.1 million child-years between 2000 and 2019 from 37 LMICs. We fitted two-way fixed-effects multivariable Poisson regression models with robust standard errors to estimate the effects of SP expansion on under-5 mortality, while assessing effect heterogeneity and performing extensive sensitivity and triangulation analyses. We subsequently integrated the retrospective data and effect estimates into validated dynamic microsimulation models based on 4.6 million child-years to forecast outcomes through 2035. Findings: A 10-percentage-point increase in SP coverage was associated with a 2·2% reduction in under-5 mortality (IRR:0·80;95%CI:0·70–0·92) between 2000 and 2019. The associations were stronger among children aged 1–4 years (IRR:0·54;95%CI:0·38–0·78), in rural populations (IRR:0·78;95%CI:0·67–0·90), and in low-income countries (IRR:0·67;95%CI:0·58–0·78). We estimated that observed SP expansion over the two-decade study period could have averted 3·34 million child deaths (95%CI:1·22–5·46). Forecasting analyses projected that achieving USP by 2035 could avert 2.46 million child deaths (95%UI:0·92–3·83) across the LMICs under study. Conversely, declines in SP coverage could lead to 1.00 million additional avoidable child deaths (95%UI:0·35–1·59). Interpretation: Achieving USP, as envisaged by target 1.3 of the 2030 Agenda for Sustainable Development, could substantially reduce child mortality in LMICs. Conversely, reduction in existing SP coverage due to declining development assistance and increasing fiscal austerity could result in substantial numbers of avoidable child deaths.
- Open Access
- 28 June 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (6) , e019240
Sexual and reproductive health needs of refugee women on Lesbos, Greece: a participatory cross-sectional study
Objective: To describe the prevalence of common sexual and reproductive health (SRH) indicators and healthcare access among women of reproductive age residing in Closed Controlled Access Centre (CCAC) Mavrovouni on Lesbos, Greece. Methods: A household survey comprising 119 questions across eight SRH domains was completed by 247 refugee women of reproductive age residing in CCAC Mavrovouni. Nine refugee coresearchers were engaged in a participatory action research process, contributing to question development, recruitment, data collection and analysis in June and July 2023. Results: Most women reported adequate antenatal care (25/28, 89%) and healthcare-assisted births (14/14, 100%), but postpartum care was suboptimal with 47% (7/15) not accessing any services despite 63% (10/16) reporting complications. About half (56/120, 47%) of women with children were single mothers. Two women had a child die at sea. Family planning showed considerable unmet need, with only 24% (42/178) of women using modern contraception and over 25% (17/66) desiring fertility treatment but none accessing it. Despite 84% (173/207) reporting adequate access to menstrual materials, only 14% (29/207) were able to consistently alleviate pain. Of 247 women, 151 (61%) experienced gynaecological symptoms yet 68 (45%) did not access healthcare. Low screening for sexually transmitted infections (43/240, 18%) and cervical cancer (1/246, 0.4%) was reported. Of 244 women, 74% (180/244) experienced verbal, 52% (127/244) physical and 36% (87/244) sexual abuse in their lifetime. Gender-based violence was most reported in home countries, during travel and during pushbacks. 54% (133/247) of women experienced at least one pushback and 23% (57/247) reported denial of medical care. Across all domains except breastfeeding, most women (67%–91%) had not received healthcare information. Conclusion: In refugee camp Mavrovouni, there is an urgent need for comprehensive SRH services that address diverse unmet health and information needs. Strengthening responses require cocreated, tailored interventions that are both data-driven and community-informed. Simultaneously, action must be taken to eliminate pushbacks and ensure equitable healthcare access irrespective of legal status.
- 28 June 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (6) , e019240
Open AccessSexual and reproductive health needs of refugee women on Lesbos, Greece: a participatory cross-sectional study
Objective: To describe the prevalence of common sexual and reproductive health (SRH) indicators and healthcare access among women of reproductive age residing in Closed Controlled Access Centre (CCAC) Mavrovouni on Lesbos, Greece. Methods: A household survey comprising 119 questions across eight SRH domains was completed by 247 refugee women of reproductive age residing in CCAC Mavrovouni. Nine refugee coresearchers were engaged in a participatory action research process, contributing to question development, recruitment, data collection and analysis in June and July 2023. Results: Most women reported adequate antenatal care (25/28, 89%) and healthcare-assisted births (14/14, 100%), but postpartum care was suboptimal with 47% (7/15) not accessing any services despite 63% (10/16) reporting complications. About half (56/120, 47%) of women with children were single mothers. Two women had a child die at sea. Family planning showed considerable unmet need, with only 24% (42/178) of women using modern contraception and over 25% (17/66) desiring fertility treatment but none accessing it. Despite 84% (173/207) reporting adequate access to menstrual materials, only 14% (29/207) were able to consistently alleviate pain. Of 247 women, 151 (61%) experienced gynaecological symptoms yet 68 (45%) did not access healthcare. Low screening for sexually transmitted infections (43/240, 18%) and cervical cancer (1/246, 0.4%) was reported. Of 244 women, 74% (180/244) experienced verbal, 52% (127/244) physical and 36% (87/244) sexual abuse in their lifetime. Gender-based violence was most reported in home countries, during travel and during pushbacks. 54% (133/247) of women experienced at least one pushback and 23% (57/247) reported denial of medical care. Across all domains except breastfeeding, most women (67%–91%) had not received healthcare information. Conclusion: In refugee camp Mavrovouni, there is an urgent need for comprehensive SRH services that address diverse unmet health and information needs. Strengthening responses require cocreated, tailored interventions that are both data-driven and community-informed. Simultaneously, action must be taken to eliminate pushbacks and ensure equitable healthcare access irrespective of legal status.